Genmab A (GMAB) Asset Utilization Ratio (2020 - 2026)

Genmab A (GMAB) reported Asset Utilization Ratio of 0.28 for Q1 2026, down 6.7% on a YoY basis from 0.3 in Q1 2025, and down 45.36% quarter-over-quarter from 0.52 in Q3 2025.

Genmab A (GMAB) Asset Utilization Ratio (2020 - 2026) Analysis & Trends

Genmab A has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.28 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio fell 6.7% year-over-year to 0.28; the trailing twelve-month figure through Mar 2026 stood at 0.28 (down 6.7% YoY), and the FY2025 full-year result was 0.38, changed N/A from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.28, down from 0.52 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.7 in Q3 2024, with the low at 0.28 in Q1 2026.
  • Historically, Asset Utilization Ratio has averaged 0.43 across 3 years, with a median of 0.33 in 2025.
  • Annual changes were most pronounced in 2025 — Asset Utilization Ratio slipped 26.43% — and 2026, when it dropped 6.7%.
  • Genmab A's Asset Utilization Ratio stood at 0.7 in 2024, then fell by 26.43% to 0.52 in 2025, then sank by 45.36% to 0.28 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.28 (Q1 2026), 0.52 (Q3 2025), and 0.33 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 0.55
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 1,422.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.47
9 Abivax 94.26 Bn 94.26 Bn - -
10 Genmab A 48.34 Bn 46.82 Bn 831.00 Mn 0.28

Historic Data

Download Data
DateValue
Mar 31, 2026 0.28
Sep 30, 2025 0.52
Jun 30, 2025 0.33
Mar 31, 2025 0.30
Sep 30, 2024 0.70
Sep 30, 2020 0.22